Thrombectomy

SEATTLE — Patients with acute ischemic stroke need access to lifesaving thrombectomy in all areas of the world, a speaker said at the 2022 American Academy of Neurology annual meeting.

Children with ischemic stroke with large vessel occlusion appear to benefit from mechanical thrombectomy, researchers reported at the International Stroke Conference.

Intra-arterial alteplase after successful reperfusion with mechanical thrombectomy for large vessel occlusion acute ischemic stroke conferred better neurological outcomes compared with placebo, a speaker reported.

Patients who present with a low Alberta Stroke Program Early Computed Tomography Score may achieve functional independence following mechanical thrombectomy, according to results of a retrospective cohort study.

Philips announced that a mechanical thrombectomy system to remove blood clots from vessels within the peripheral arterial and venous systems has received 510(k) clearance from the FDA and is now available in the U.S.

For U.S. patients with acute ischemic stroke, late mechanical thrombectomy combined with standard medical care was found to be a cost-effective option compared with standard care alone, researchers reported.

Penumbra announced that it has launched its next-generation aspiration system for peripheral thrombectomy, which received FDA clearance in June.

Patients who underwent thrombectomy within 8 hours after the onset of stroke symptoms in addition to standard care had better functional outcomes at 90 days than those treated with standard care alone, researchers reported.

Among patients with acute ischemic stroke from large-vessel occlusion, endovascular thrombectomy alone was noninferior for 90-day functional outcomes to IV alteplase administered within 4.5 hours from symptom onset plus endovascular thrombectomy.

LAS VEGAS — In the EXTRACT-PE trial, an aspiration mechanical thrombectomy device was safe and effective among patients with acute pulmonary embolism, researchers reported at VIVA 19.